Blackstone’s BioMed Realty to double UK life sciences portfolio

The Blackstone portfolio company, BioMed Realty, has announced plans to double its life sciences holdings in the UK through two strategic deals in Cambridge.

Would you like to read more? Log in first (top right of the screen) or take a trial.